![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Teleglobal’s Chest Abnormality Detection Software Awarded CE Mark
Teleglobal’s Chest Abnormality Detection Software Awarded CE Mark
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
June 17, 2021
Teleglobal Consulting UK’s artificial intelligence software for detecting chest abnormalities has received a CE mark.
The software, sold under the brand name iDoc.ai, can detect 13 types of chest conditions, including those caused by COVID-19.
The software also has certification under ISO 13485, and is now available in Europe and other markets that accept the CE mark.
Upcoming Events
-
21Oct